Tumor cells broadly recognized via NK activating receptors and death receptor pathways

This entry does not represent a single molecular target but rather describes a complex biological mechanism involving the recognition and elimination of malignant cells by Natural Killer (NK) cells. This process is mediated through two primary axes: the engagement of NK-activating receptors, such as NKG2D, NKp30, and DNAM-1, by ligands that are typically upregulated on stressed or transformed cells [1]. Simultaneously, NK cells can induce programmed cell death via the extrinsic apoptosis pathway by utilizing ligands like FASL and TRAIL to trigger death receptors (FAS, DR4, and DR5) on the tumor cell surface [2]. In oncology, this dual mechanism is a focal point for immunotherapy, where therapeutic agents are designed to either enhance NK cell activation or sensitize tumor cells to death receptor-mediated killing [3]. Because the input describes a broad physiological process involving multiple distinct protein families and cell-to-cell interactions rather than a specific protein or gene, it is classified as an incorrect target designation for structured molecular databases [4].

Other names

NK cell-mediated cytotoxicityExtrinsic apoptosis pathwayNK cell immunosurveillanceNatural killer cell-mediated tumor recognition

Induction of tumor cell lysis through the activation of Natural Killer (NK) cell receptors (e.g., NKG2D, NCRs) and the triggering of extrinsic apoptotic signaling via death receptors (e.g., FAS, TRAIL-R1/2).